Insider trading

Period: 120 months Stock: PBYI + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

263 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

263 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

263 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

263 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
263 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
263 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

263 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
8 Jun 2017
ADAGE CAPITAL PARTNERS GP, L.L.C. 10% owner · indirect
Sold, plan not stated 2×
$8.09M 100,000 at 80.95
2.5%
5 Jun 2017
ADAGE CAPITAL PARTNERS GP, L.L.C. 10% owner · indirect
Sold, plan not stated 7×
$28.04M 307,128 at 91.29
7.2%
2 Jun 2017
ADAGE CAPITAL PARTNERS GP, L.L.C. 10% owner · indirect
Sold, plan not stated
$2.53M 30,475 at 83.06
0.7%
1 Jun 2017
ADAGE CAPITAL PARTNERS GP, L.L.C. 10% owner · indirect
Sold, plan not stated 2×
$13.98M 169,525 at 82.45
3.8%
26 May 2017
ADAGE CAPITAL PARTNERS GP, L.L.C. 10% owner · indirect
Sold, plan not stated 3×
$23.12M 300,000 at 77.07
6.3%
25 May 2017
ADAGE CAPITAL PARTNERS GP, L.L.C. 10% owner · indirect
Sold, plan not stated 4×
$31.15M 400,000 at 77.87
7.8%
24 May 2017
ADAGE CAPITAL PARTNERS GP, L.L.C. 10% owner · indirect
Sold, plan not stated 7×
$38.88M 535,700 at 72.57
9.4%
1 Feb 2017
CHARNAS ROBERT See Remarks
Sold, plan not stated 2×
$95.75K 3,008 at 31.83
10.2%
20 Jan 2017
AUERBACH ALAN H PRESIDENT AND CEO
Sold, plan not stated
$339.06K 10,202 at 33.24
0.2%
20 Jan 2017
CHARNAS ROBERT See Remarks
Sold, plan not stated
$76.21K 2,293 at 33.24
7.2%
20 Jan 2017
BRYCE RICHARD PAUL SR VP, CLINICAL RESEARCH & DEV
Sold, plan not stated
$76.21K 2,293 at 33.24
7.3%
20 Jan 2017
Lo Steven Chief Commercial Officer
Sold, plan not stated
$76.11K 2,290 at 33.24
7.3%
20 Jan 2017
EYLER CHARLES R SEE REMARKS
Sold, plan not stated
$27.25K 820 at 33.24
7.8%
Showing 251–263 of 263. ← Newer Page 6 of 6